Notably, our study enriched the understanding of the regulation of LINC01138 expression, occurring at the genomic level (copy number amplification), transcriptional level (activated by AR)27, and post-transcriptional level (stabilized by IGF2BP1 and IGF2BP3) in HCC cells. The gene discussed is IGF2BP3; the disease is hepatocellular carcinoma.